// App-Quantinova.ai

3214 : A fully human anti-TIM3 antibody with co-stimulatory activity

Researchers

Presenter

  • J Dixon Gray

Principal Investigators

  • Irina Krapf

  • Heyue Zhou

  • Gunnar Kaufmann

Medical Centers

  • Sorrento Therapeutics Inc, San Diego, CA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Cluster of Differentiation 25

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A